Barry Lynch
About Barry Lynch
Barry Lynch is the Director of Business Development (EMEA) at Alamar Biosciences, Inc., specializing in engaging research leadership across Pharma, Biotech, and University Medical Centres. With extensive experience in sales and marketing within the biopharma sector, he focuses on customer acquisition strategies and process efficiency.
Work at Alamar Biosciences
Barry Lynch serves as the Director of Business Development (EMEA) at Alamar Biosciences, Inc., a position he has held since 2023. In this role, he specializes in engaging research leadership across the pharmaceutical and biotech sectors, as well as university medical centers. His focus is on effectively positioning new paradigms within established workflows, which is critical for advancing business development initiatives in the EMEA region.
Education and Expertise
Barry Lynch holds a Master of Science in Biotechnology from Abertay University, which he completed in 1997. He also earned a Bachelor of Science with Honours in Biochemistry from the University of Dundee, graduating in 1996. His educational background supports his expertise in navigating the complexities of the Biopharma-CRO ecosystem, particularly in industrial and translational research markets.
Background
Barry Lynch has extensive experience in business development and sales within the life sciences sector. His career includes roles at various organizations, such as Invitrogen, Ultivue, and Advanced Cell Diagnostics. He has worked in multiple capacities, including Sales Specialist, Marketing Manager, and Commercial Director, across different regions, including EMEA and Asia Pacific. His diverse background equips him with a comprehensive understanding of market dynamics and customer acquisition strategies.
Achievements
Throughout his career, Barry Lynch has been instrumental in securing additional rounds of financing by engaging with board teams and venture capitalists. He is known for his ability to demystify complex high-tech products and services, effectively communicating value propositions and business models. His proven track record includes building market leadership in areas such as proteomics and spatial transcriptomics, contributing to advancements in the life sciences industry.
Previous Positions
Before joining Alamar Biosciences, Barry Lynch held several significant positions. He worked as Vice President of Global Sales at Ultivue from 2020 to 2021, and as Commercial Director (EMEA) from 2018 to 2020. His earlier roles include Business Development Manager at Oxford Immunotec and Marketing Manager at Life Technologies. His varied experiences across these roles have shaped his strategic approach to business development and sales in the life sciences sector.